$ARCT
Arcturus Therapeutics Holdings Inc
PRICE
$29 β²2.149%
Extented Hours
VOLUME
201,162
DAY RANGE
26.715 - 28.8
52 WEEK
11.7 - 33.8
Join Discuss about ARCT with like-minded investors
@CarlosH-carvan #ivtrades
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Nov. 1, 2021: NTLA, BEAM, PATH, KTOS, VLD, NIU, BLDE, MKFG, ZM, GENI, EXAS, CDNA, ALLO, VERV, ARCT, ADPT, TWLO, HOOD, TOST
139 Replies 15 π 14 π₯
Key Metrics
Market Cap
756.51 M
Beta
1.85
Avg. Volume
402.91 K
Shares Outstanding
26.56 M
Yield
0%
Public Float
0
Next Earnings Date
2023-08-08
Next Dividend Date
Company Information
founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the companyβs aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.
Website: arcturusrx.com
HQ: ,
Related News